Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
AstraZeneca
Genmab
PMV Pharmaceuticals, Inc
STORM Therapeutics LTD
Genmab
Tubulis GmbH
Alentis Therapeutics AG
Eli Lilly and Company
Neonc Technologies, Inc.
Ipsen
Sumitomo Pharma America, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
PT. Prodia Stem Cell Indonesia
Merus B.V.
Arvinas Inc.
Aulos Bioscience, Inc.
Exscientia AI Limited
Betta Pharmaceuticals Co., Ltd.
Theravectys S.A.
Amgen
One-carbon Therapeutics AB
Takeda
Perspective Therapeutics
Radiopharm Theranostics, Ltd
Second Life Therapeutics
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Eli Lilly and Company
Hoffmann-La Roche
Kura Oncology, Inc.
Inhibrx Biosciences, Inc
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
VM Oncology, LLC
Tanabe Pharma America, Inc.
Takeda
MediLink Therapeutics (Suzhou) Co., Ltd.
DualityBio Inc.
BicycleTx Limited
Volastra Therapeutics, Inc.
Dragonfly Therapeutics
Eli Lilly and Company
ITM Oncologics GmbH
Immunitas Therapeutics
BeiGene
Sichuan Baili Pharmaceutical Co., Ltd.
LigaChem Biosciences, Inc.
Scancell Ltd
Coordination Pharmaceuticals, Inc.